Navigation Links
Obesity Significantly Increases Side Effects of Stereotactic Body Radiation Therapy in Lung Cancer Patients
Date:11/2/2009

CHICAGO, Nov. 2 /PRNewswire-USNewswire/ -- Obesity, not the amount of radiation given, is the greatest factor in whether early-stage lung cancer patients develop chest wall pain after receiving stereotactic body radiation therapy to the chest wall, with obese patients being more than twice as likely to develop chronic pain compared to those who have less body weight, according to a first-of-its-kind study presented Tuesday, November 3, 2009, at the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO).

Researchers studied other factors associated with obesity, such as diabetes, to find out why obesity in patients increased chest wall pain. Findings show that obese patients who are diabetic are over three times more likely to develop chest wall pain after receiving stereotactic body radiation therapy to the chest wall, compared to patients who do not have diabetes.

"The study shows that physiological factors, such as obesity and diabetes, can play a major role in the development of radiation-related toxicity," James Welsh, M.D., lead author of the study and a radiation oncologist at the M.D. Anderson Cancer Center in Houston said. "This is a surprising finding, since most side effects of radiation treatment are based on the amount of normal tissue that is treated and the volume of the dose."

The main purpose of the study was to find out what the highest amount of radiation that could be delivered to the chest wall using a specialized type of radiation treatment called stereotactic body radiation therapy (SBRT) without patients developing the late side effects of pain and skin reactions. The study shows that patients who receive a high dose of radiation to cancer close to the chest wall (in the amount of 35 gray (Gy)) have an increased chance of having pain and skin reactions, compared to those who have a lower radiation dose.

SBRT is a specialized type of external beam radiation therapy that pi
'/>"/>

SOURCE American Society for Radiation Oncology
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting
2. Orexigen(R) Therapeutics Releases New Efficacy Data for Contrave(R) in Late Breaker Presentations at the 27th Annual Scientific Meeting of The Obesity Society
3. Amylin Pharmaceuticals Highlights New Data Supporting Therapeutic Potential of Obesity Pipeline at Obesity 2009
4. A Unique Endoluminal Approach for the Treatment of Morbid Obesity Selected for Presentation at the 2009 American College of Surgeons Clinical Congress
5. Arena Pharmaceuticals Lorcaserin to be Featured in Multiple Presentations at Obesity 2009
6. Orexigen(R) Therapeutics Schedules September 30, 2009 Teleconference and Webcast to Discuss Phase 2b Trial Results From Second Obesity Drug Candidate, Empatic(TM)
7. Is Obesity an Oral Bacterial Disease?
8. Isis Highlights New Data on Antisense Drugs to Treat Type 2 Diabetes and Obesity at ADA Scientific Sessions
9. Results From Phase 3 EQUATE Trial of VIVUS Qnexa Highlighted at European Congress on Obesity
10. Complications and Costs for Obesity Surgery Declining
11. Obesity Associated With Higher Risk for Urinary Tract Infections
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Inc. and Alzheimer,s Weekly today announced the winners of ... designed to help five seniors in their fight to ... five winners will receive a $2,500 Dakim BrainFitness System, ... their brain health and the most widely adopted product ... country. ,, The contest, held to coincide ...
(Date:12/15/2009)... Tenn., Dec. 15 Medical researchers with ... with their revolutionary new technology for a simple ... ,, Following the success of its pre-clinical ... a patent on the biomarker, CA11-19, and all ... blood test, ColoMarker(TM) will detect colon cancer in ...
(Date:12/15/2009)... medical expert internationally recognized as a leading authority ... last month to suspend Doug Barron for doping ... the medical condition hypogonadism and was ... and discriminatory." ,, Hypogonadism is the ... referred to informally as Low T . ...
Breaking Medicine Technology:5 Seniors Win $2,500 Dakim BrainFitness System to Fight Alzheimer's 25 Seniors Win $2,500 Dakim BrainFitness System to Fight Alzheimer's 3Researchers Announce Medical Breakthrough with Simple, Inexpensive Blood Test for Colon Cancer 2Harvard Medical Expert Criticizes PGA Tour, Calls Decision to Suspend Doug Barron for Doping 'Unreasonable, Unfair and Discriminatory' 2Harvard Medical Expert Criticizes PGA Tour, Calls Decision to Suspend Doug Barron for Doping 'Unreasonable, Unfair and Discriminatory' 3Harvard Medical Expert Criticizes PGA Tour, Calls Decision to Suspend Doug Barron for Doping 'Unreasonable, Unfair and Discriminatory' 4Engineers produce how to guide for controlling the structure of nanoparticles 14270 1Engineers produce how to guide for controlling the structure of nanoparticles 14270 2Antidepressants Linked to Heart Defects in Newborns 58322 1Antidepressants Linked to Heart Defects in Newborns 58322 2Antidepressants Linked to Heart Defects in Newborns 58322 3Research network based at University of Toronto gets 245 million boost to speed up cancer detection 10104 1Research network based at University of Toronto gets 245 million boost to speed up cancer detection 10104 2
... at ACG Annual Scientific Meeting -, ORLANDO, ... Inc.) and Forest Laboratories,Inc. (NYSE: FRX ) ... Phase,2b study assessing linaclotide,s safety and efficacy in ... Analysis of the data,indicates that once- daily oral ...
... and value in,moderate to severe Crohn,s disease patients ... Fla. Oct. 7 Data from two studies,presented ... of Gastroenterology,(ACG) Annual Meeting demonstrate that CIMZIA(R) (certolizumab ... Factor alpha) - provides,sustained improvement in symptoms with ...
Other Medicine Technology:Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 2Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 3Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 4Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 5CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 2CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 3CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 4CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 5CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 6CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 7CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 8CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 9
(Date:12/15/2009)... advocates to be leaders in the fight against ... from experts in online learning, the Masie Center ... ONE and Malaria No ... the first-ever "Malaria Griots" program, a dynamic education ... become leaders in the fight against malaria. ...
(Date:12/15/2009)... PLAINS, N.Y., Dec. 15 Team In ... groundbreaking charity sports training program, has ... to support blood cancer research and patient services. ... been the pre-eminent charity endurance sports training program, ... marathon, half marathon, triathlon, 100-mile century cycle ride ...
(Date:12/15/2009)... -- The new compact LifeSpan TR200 folding treadmill, made ... ), was highly praised by treadmill review groups in ... compact TR200 folding treadmill received awards for Best New ... ,, The compact LifeSpan TR200 treadmill is designed ... "This category buster is a very compact treadmill that ...
(Date:12/15/2009)... is known to reduce depression and fatigue in people ... this effect stems from an individual,s sense of mastery ... to achieve certain physical goals. , The study ... "We base our arguments on fatigue being a symptom ... and community health at the University of Illinois and ...
(Date:12/15/2009)... has led the fight against malaria, and I am encouraged ... global strategies for ending malaria deaths are working,” said Dr. Daniel ... , ... Washington, D.C. (Vocus) December 15, 2009 -- ... led the fight against malaria, and I am encouraged to see ...
Breaking Medicine News(10 mins):Health News:ONE and Malaria No More Launch 'Malaria Griots' 2Health News:ONE and Malaria No More Launch 'Malaria Griots' 3Health News:ONE and Malaria No More Launch 'Malaria Griots' 4Health News:$1 Billion - For Charity! 2Health News:$1 Billion - For Charity! 3Health News:Treadmill Reviews Rate Compact LifeSpan Treadmill Best Treadmill 2Health News:Mastery of physical goals lessens disease-related depression and fatigue 2Health News:Statement by Dr. Daniel Carucci, Vice President for Global Health for the United Nations Foundation, on Progress Shown in World Malaria Report 2009 2
... Eli Lilly and Company,(NYSE: LLY ) ... F.R.C.P.,will join Lilly in January, 2008, as Executive ... for development of Lilly,s,expanding diabetes and obesity R&D ... Medical Fellow, Diabetes and Endocrine, who will,retire at ...
... Coil for Prostate MR Now Available for All Three Major MR ... ... today announced the,availability of the 3.0T Prostate eCoil (TM) MR Endorectal ... MEDRAD,introduced the 3.0T prostate eCoil for GE scanners in 2006. ...
... ... BURNIE, Md., Sept. 18 After 38 years at,Baltimore Washington ... Walker has announced his intention to retire by June 2008. ... Directors meeting. (Photo: http://www.newscom.com/cgi-bin/prnh/20070918/DCTU027 ) "I ...
... new grants will speed development of TB vaccines, diagnostic tests, ... drugs in support of the Global Plan ... & Melinda Gates,Foundation announced today grants totaling $280 million to ... earth and,kills nearly 2 million yearly - mostly in the ...
... ,Smurfit-Stone Container Corporation,s paper mill in Hodge, LA, ... achieve 2 million hours worked without,a recordable accident ... The 2 million hours worked covered 539,days. ... has set a new standard for our mill ...
... Ill., Sept. 18 The,National Quality Forum (NQF) and The ... M. Eisenberg Patient Safety and Quality,Awards. Honorees were selected in ... are as follows:, INDIVIDUAL ACHIEVEMENT (2 RECIPIENTS), -- ... and Prevention at The Children,s Hospital ...
Other Medicine News:Health News:Robert J. Heine, M.D., Ph.D., F.R.C.P. to Join Lilly; Distinguished Diabetes Expert to Lead Diabetes/Endocrine Medical Division 2Health News:MEDRAD Announces eCoil(TM) for Siemens, Philips 3.0T MR Scanners 2Health News:MEDRAD Announces eCoil(TM) for Siemens, Philips 3.0T MR Scanners 3Health News:BWMC President and CEO Announces Retirement 2Health News:BWMC President and CEO Announces Retirement 3Health News:Gates Foundation Commits $280 Million for Research to Fight Global TB Epidemic 2Health News:Gates Foundation Commits $280 Million for Research to Fight Global TB Epidemic 3Health News:Gates Foundation Commits $280 Million for Research to Fight Global TB Epidemic 4Health News:Smurfit-Stone's Hodge, LA, Mill Becomes First to Achieve Safety Milestone 2Health News:2007 John M. Eisenberg Patient Safety and Quality Award Recipients Announced 2Health News:2007 John M. Eisenberg Patient Safety and Quality Award Recipients Announced 3Health News:2007 John M. Eisenberg Patient Safety and Quality Award Recipients Announced 4Health News:2007 John M. Eisenberg Patient Safety and Quality Award Recipients Announced 5
... Ulti-Mist™ HME product line has the right ... to adults and from intubated patients to ... humidification for both anesthesia and critical care ... provide maximum protection for patients and staff ...
The Pall High Performance HME is a high efficiency heat and moisture exchanger, indicated to protect patients against the potential risks of ventilation with dry and cold gases....
Passive heat and moisture exchangers for respiratory applications....
Passive heat and moisture exchangers for respiratory applications....
Medicine Products: